Literature DB >> 22016859

Potential origins and horizontal transfer of type III secretion systems and effectors.

Nat F Brown1, B Brett Finlay.   

Abstract

A major virulence mechanism used by pathogenic Gram-negative bacteria is the delivery of effector proteins from the bacterial cytoplasm into host cells by type III secretion. Typically, genes encoding type III secretion systems (T3SS) and effectors have been horizontally acquired by the bacteria that employ them. In proteobacteria, and especially Salmonella, and attaching and effacing (A/E) pathogens, the genetic structure of these systems presents as a large locus encoding a T3SS with a small number of effectors, plus numerous small unlinked loci encoding additional individual effectors. We discuss the generation of novel effectors, and the evolution of G+C content following acquisition. We also consider the currently held view that each locus has been acquired individually, as well as propose an alternative where recombination may have redistributed and broken up clusters of effectors. It is clear that the evolution of this virulence strategy is highly complex and challenging to analyze.

Year:  2011        PMID: 22016859      PMCID: PMC3190322          DOI: 10.4161/mge.1.2.16733

Source DB:  PubMed          Journal:  Mob Genet Elements        ISSN: 2159-2543


  28 in total

1.  Revisiting the chlamydial type III protein secretion system: clues to the origin of type III protein secretion.

Authors:  J F Kim
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

Review 2.  Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei.

Authors:  Guang Wen Sun; Yunn-Hwen Gan
Journal:  Trends Microbiol       Date:  2010-10-15       Impact factor: 17.079

3.  Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella.

Authors:  William Wiley Navarre; Steffen Porwollik; Yipeng Wang; Michael McClelland; Henry Rosen; Stephen J Libby; Ferric C Fang
Journal:  Science       Date:  2006-06-08       Impact factor: 47.728

4.  Virulence is positively selected by transmission success between mammalian hosts.

Authors:  Mark E Wickham; Nat F Brown; Erin C Boyle; Brian K Coombes; B Brett Finlay
Journal:  Curr Biol       Date:  2007-04-19       Impact factor: 10.834

Review 5.  Evolution of the type III secretion system and its effectors in plant-microbe interactions.

Authors:  Honour C McCann; David S Guttman
Journal:  New Phytol       Date:  2008       Impact factor: 10.151

Review 6.  Selection on codon bias.

Authors:  Ruth Hershberg; Dmitri A Petrov
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

7.  Parallel evolution of virulence in pathogenic Escherichia coli.

Authors:  S D Reid; C J Herbelin; A C Bumbaugh; R K Selander; T S Whittam
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

8.  Association between translation efficiency and horizontal gene transfer within microbial communities.

Authors:  Tamir Tuller; Yana Girshovich; Yael Sella; Avi Kreimer; Shiri Freilich; Martin Kupiec; Uri Gophna; Eytan Ruppin
Journal:  Nucleic Acids Res       Date:  2011-02-22       Impact factor: 16.971

9.  Terminal reassortment drives the quantum evolution of type III effectors in bacterial pathogens.

Authors:  John Stavrinides; Wenbo Ma; David S Guttman
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

10.  H-NS mediates the silencing of laterally acquired genes in bacteria.

Authors:  Sacha Lucchini; Gary Rowley; Martin D Goldberg; Douglas Hurd; Marcus Harrison; Jay C D Hinton
Journal:  PLoS Pathog       Date:  2006-08       Impact factor: 6.823

View more
  8 in total

1.  Escherichia coli type III secretion system 2 (ETT2) is widely distributed in avian pathogenic Escherichia coli isolates from Eastern China.

Authors:  S Wang; X Liu; X Xu; Y Zhao; D Yang; X Han; M Tian; C Ding; D Peng; S Yu
Journal:  Epidemiol Infect       Date:  2016-04-22       Impact factor: 4.434

2.  The Shigella Spp. Type III Effector Protein OspB Is a Cysteine Protease.

Authors:  Thomas E Wood; Kathleen A Westervelt; Jessica M Yoon; Heather D Eshleman; Roie Levy; Henry Burnes; Daniel J Slade; Cammie F Lesser; Marcia B Goldberg
Journal:  mBio       Date:  2022-05-31       Impact factor: 7.786

3.  Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer.

Authors:  Weiguang Chen; Fanlong Liu; Zongxin Ling; Xiaojuan Tong; Charlie Xiang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

4.  Evolutionary Dynamics of Pathoadaptation Revealed by Three Independent Acquisitions of the VirB/D4 Type IV Secretion System in Bartonella.

Authors:  Alexander Harms; Francisca H I D Segers; Maxime Quebatte; Claudia Mistl; Pablo Manfredi; Jonas Körner; Bruno B Chomel; Michael Kosoy; Soichi Maruyama; Philipp Engel; Christoph Dehio
Journal:  Genome Biol Evol       Date:  2017-03-01       Impact factor: 3.416

5.  Identification and characterization of putative Aeromonas spp. T3SS effectors.

Authors:  Luiz Thiberio Rangel; Jeremiah Marden; Sophie Colston; João Carlos Setubal; Joerg Graf; Johann Peter Gogarten
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

6.  The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients.

Authors:  Bo Zhou; Chaoyang Sun; Jia Huang; Meng Xia; Ensong Guo; Na Li; Hao Lu; Wanying Shan; Yifan Wu; Yuan Li; Xiaoyan Xu; Danhui Weng; Li Meng; Junbo Hu; Qinglei Gao; Ding Ma; Gang Chen
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379

7.  A horizontally acquired transcription factor coordinates Salmonella adaptations to host microenvironments.

Authors:  Nat F Brown; Lindsay D Rogers; Kristy L Sanderson; Joost W Gouw; Elizabeth L Hartland; Leonard J Foster
Journal:  mBio       Date:  2014-09-23       Impact factor: 7.867

8.  A bacterial toxin-antitoxin module is the origin of inter-bacterial and inter-kingdom effectors of Bartonella.

Authors:  Alexander Harms; Marius Liesch; Jonas Körner; Maxime Québatte; Philipp Engel; Christoph Dehio
Journal:  PLoS Genet       Date:  2017-10-26       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.